Optic Nerve Glioma

Overview

4.5 out of 5 (6 Reviews)

Credits

1.00

Pharmacology Credits

0.5

Post Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

26 Mar 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Optic nerve gliomas are benign tumors categorized as pilocytic astrocytomas and represent a significant portion of primary optic nerve tumors. They comprise around half of all primary optic nerve tumor cases and 1.5% to 4% of all orbital tumors. These tumors pose challenges in understanding their natural course and appropriate treatment strategies. They are part of a spectrum of primary tumors affecting the optic nerve, encompassing various entities such as optic nerve sheath meningioma and ganglioglioma. Optic pathway gliomas, including optic nerve gliomas, arise from the pre-cortical optic pathways and may present sporadically or in association with neurofibromatosis type 1 (NF1). Therefore, genetic testing for NF1 is recommended due to its association with optic pathway gliomas.

Although biopsy is usually unnecessary for diagnosis, advancements in molecularly targeted therapies may make genetic testing increasingly valuable. The initial evaluation includes magnetic resonance imaging of the brain and orbit to determine the tumor's location and guide treatment decisions. Management of optic gliomas necessitates an interprofessional healthcare team, including support from psychologists and ocularists, with evolving treatment options that emphasize achieving an optimal prognosis for affected patients. This activity reviews the evaluation of optive nerve gliomas in patients, with particular emphasis placed on the currently evolving treatment options and recommendations, highlighting the optimal prognosis for patients with this condition.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the clinical features and imaging characteristics of optic nerve gliomas.

  • Implement evidence-based treatment strategies for optic nerve gliomas based on tumor location and patient characteristics.

  • Select appropriate surgical or medical interventions for optic nerve gliomas based on individual patient needs.

  • Collaborate with a multidisciplinary healthcare team, including neuro-ophthalmologists, oncologists, surgeons, and geneticists, to coordinate long-term follow-up and supportive care for patients with optic nerve gliomas and their families.

  • Outline the pharmacologic therapy as it applies to Optic Nerve Glioma

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurse Practitioners: StatPearls designates this activity for 1.00 ANCC contact hour(s), which includes 0.5 hour(s) of pharmacology. NPs should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Murchana K. on 9/30/2022

Dr Jagveer S. on 6/19/2023

MARINA K. on 9/22/2023

Akshaya K. on 11/15/2023

Dr Sruthi G. on 1/18/2024

Malani K. on 4/18/2024

Unlimited Nurse Practitioner CE

Stay up to date on the latest medical knowledge with 6675 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7930 hours of CE.

Single Activity

Take this single activity

$49 1 activity

6 Month Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$379 per half year per user

1 Year Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$579 per 1 year per user